Indegene
Helps global healthcare organizations address complex challenges by seamlessly integrating analytics and technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 Valuation: €0.0 4.8x EV/Revenue 25.1x EV/EBITDA | round | |
| N/A | €0.0 | round | |
* | N/A | Post IPO Equity | |
| Total Funding | 000k | ||
| INR | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 72 % | 39 % | 12 % | 10 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 27 % | 18 % | 19 % | 22 % | 23 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 15 % | 10 % | 12 % | 13 % | 14 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.
Tech stack
Investments by Indegene
Edit
